Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,163,859
  • Shares Outstanding, K 217,692
  • Annual Sales, $ 51,950 K
  • Annual Income, $ -265,940 K
  • EBIT $ -270 M
  • EBITDA $ -266 M
  • 60-Month Beta 0.91
  • Price/Sales 43.03
  • Price/Cash Flow N/A
  • Price/Book 3.34

Options Overview Details

View History
  • Implied Volatility 93.59% (+4.46%)
  • Historical Volatility 115.17%
  • IV Percentile 74%
  • IV Rank 15.00%
  • IV High 363.10% on 02/13/26
  • IV Low 46.01% on 08/22/25
  • Expected Move (DTE 3) 0.27 (2.69%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 1,529
  • Volume Avg (30-Day) 9,545
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 169,608
  • Open Int (30-Day) 188,273
  • Expected Range 9.83 to 10.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.32
  • Number of Estimates 6
  • High Estimate -0.30
  • Low Estimate -0.32
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +13.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.23 +61.31%
on 02/17/26
11.50 -12.61%
on 03/03/26
+1.02 (+11.30%)
since 02/10/26
3-Month
6.23 +61.31%
on 02/17/26
15.57 -35.45%
on 12/11/25
-5.36 (-34.78%)
since 12/10/25
52-Week
5.80 +73.28%
on 04/09/25
16.44 -38.87%
on 12/08/25
+2.40 (+31.37%)
since 03/10/25

Most Recent Stories

More News
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

OCUL : 10.02 (+0.80%)
3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

CVBF : 19.22 (-0.10%)
VC : 91.15 (-0.73%)
OCUL : 10.02 (+0.80%)
3 of Wall Street’s Favorite Stocks We’re Skeptical Of

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

MSTR : 140.48 (+1.10%)
SBH : 15.36 (+5.28%)
OCUL : 10.02 (+0.80%)
Ocular Therapeutix (OCUL) Stock Trades Down, Here Is Why

Ocular Therapeutix (OCUL) Stock Trades Down, Here Is Why

OCUL : 10.02 (+0.80%)
1 Russell 2000 Stock Worth Investigating and 2 We Avoid

1 Russell 2000 Stock Worth Investigating and 2 We Avoid

SCVL : 19.65 (+3.97%)
ASTH : 23.57 (-4.65%)
OCUL : 10.02 (+0.80%)
Ocular Therapeutix™ to Participate in March Investor Conferences

BEDFORD, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 10.02 (+0.80%)
Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations

Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March...

OCUL : 10.02 (+0.80%)
1 Volatile Stock for Long-Term Investors and 2 Facing Challenges

1 Volatile Stock for Long-Term Investors and 2 Facing Challenges

OSCR : 13.70 (-1.86%)
MAR : 331.40 (+0.77%)
OCUL : 10.02 (+0.80%)
Ocular Therapeutix™ Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF treatment Superiority primary endpoint met with 74.1%...

OCUL : 10.02 (+0.80%)
Ocular Therapeutix™ to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026

Ocular to host webcast scheduled for Tuesday, February 17, 2026, at 8:00 AM ET Detailed SOL-1 data to be presented at the 49 th Macula Society Annual Meeting BEDFORD, Mass., Feb. 13, 2026...

OCUL : 10.02 (+0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 10.69
2nd Resistance Point 10.47
1st Resistance Point 10.20
Last Price 10.02
1st Support Level 9.72
2nd Support Level 9.50
3rd Support Level 9.24

See More

52-Week High 16.44
Fibonacci 61.8% 12.38
Fibonacci 50% 11.12
Last Price 10.02
Fibonacci 38.2% 9.86
52-Week Low 5.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar